Skip to content

ARP versus SH

Alveolar ridge preservation (ARP) versus spontaneous healing in large buccal bone defects after tooth extraction in the posterior mandible. - alveolar ridge preservation versus spontaneous healing

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
NL-OMON
Registry ID
NL-OMON57733
Enrollment
66
Registered
2025-02-13
Start date
2025-08-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Insufficient alveolar bone in the mandible

Interventions

Intake Patients will be seen by an experienced surgeon (JP) and a treatment plan will be set up in close cooperation with the referring dentist. Before the surgical procedure, a periapical x-ray pictu
ExtractionPre-operative protocol consists of 2g amoxicillin 1 hour pre-operative according to the clinical guideline. A-traumatic flapless extraction by an experienced surgeon (JP) using elevators and
The measurements will be performed in three dimensions (Figure 1):&nbsp
Buccal bone height (a)&nbsp
The height from the most apical part of the alveole to the most coronal part of the alveoleWidth in mesiodistal direction (b)The width from the mesial crest to the distal crestWidth in buccolingual di
Patients will be included it there is &gt
50% buccal height bone loss&nbsp
Randomization to either the XG-group, AG-group or control group will take place.In the XG-groep, ARP is performed by using a XG (Cerabone® plus, botiss biomaterials GmbH, Zossen, Germany) and coverage

Sponsors

Erasmus MC, Universitair Medisch Centrum Rotterdam
Lead Sponsor

Eligibility

Age
18 Years to 99 Years

Inclusion criteria

Inclusion criteria: A minimum age of 18 years old In need for extraction of a single (pre)molar in the mandible that needs to be replaced by an implantAt least one adjacent tooth A buccal bone defect after extraction of 50% or more 

Exclusion criteria

Exclusion criteria: Active periodontal diseaseUncontrolled diabetes mellitusHistory of or current chemotherapy or radiation in the head and neck areaHistory of or current use of medication related to osteonecrosis of the jawHeavy and moderate smokers (>5 cigarettes a day) Unable to maintain basic oral health (physical and/or mental)Pregnancy (in case of pregnancy, the treatment is postponed until after the delivery)

Design outcomes

Primary

MeasureTime frame
The primary endpoint of this study is the frequency of additional bone augmentation at implant placement. 

Secondary

MeasureTime frame
Objective Clinician-reported outcome measuresImplant survivalImplant successKeratinized mucosal width (KMW) Pocket probing depth (PPD) Bleeding on probing (BOP)Surgical complications (swelling, dehiscence, haemorrhage, infection) RadiographicMarginal bone levels (MBL)Volumetric changes of the boneProfilometricVolumetric changes of the soft tissueEstheticSee PROMsTechnicalProsthetic successHistologicalHistological analysisMicro-computed tomography (µCT) analysisSubjective Clinician-reported outcome measures related to the clinician’s perceptionClinician questionnaire using an 11-point numeric scale assessing difficulty of the procedurePROMSPatient questionnaire based on a VAS score (0-10) assessing satisfaction, pain, swelling and impact of the surgeryOrofacial Esthetic Scale (OES-NL) assessing the esthetics of the tooth Chair TimeChair time in minutesCostsCosts in euros 

Countries

Netherlands

Contacts

Public ContactA Jue

Erasmus MC, Universitair Medisch Centrum Rotterdam

a.jue@erasmusmc.nl(010) 704 01 27

Outcome results

None listed

Source: NL-OMON (via WHO ICTRP) · Data processed: Feb 3, 2026